Detre S, Saclani Jotti G, Dowsett M
Academic Department of Biochemistry, Royal Marsden Hospital, Fulham, London.
J Clin Pathol. 1995 Sep;48(9):876-8. doi: 10.1136/jcp.48.9.876.
Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. The most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue. A "quickscore" has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the IHA quickscore for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quickscore and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score. A positive cut off quickscore of > or = 3 has been suggested.
免疫组织化学在评估乳腺癌预后标志物方面的应用越来越广泛。半定量分析常常是必要的,但目前除了使用图像分析外,现有的方法都很繁琐。最常用的方法是H评分,它结合了乳腺癌组织中染色强度以及阳性染色细胞的百分比。已经开发出一种“快速评分”方法,无需对单个细胞进行计数。定量生化雅培酶免疫测定法(EIA)和采用半定量H评分的达科免疫组织化学测定法(IHA),已被用作标准,用于测试雌激素受体表达半定量的IHA快速评分。快速评分与EIA之间发现了良好的相关性,与H评分和EIA之间的相关性一样好。快速评分是一种有效的方法,使用更严格的H评分没有优势。有人建议将快速评分的阳性临界值设定为≥3。